• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳酸酐酶抑制剂:2-取代-1,3,4-噻二唑-5-磺酰胺对线粒体同工酶VA和VB的抑制作用强且具有选择性,对胞质及膜相关的碳酸酐酶I、II和IV的抑制作用较弱。

Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.

作者信息

Smaine Fatma-Zohra, Pacchiano Fabio, Rami Marouan, Barragan-Montero Véronique, Vullo Daniela, Scozzafava Andrea, Winum Jean-Yves, Supuran Claudiu T

机构信息

Institut des Biomolécules Max Mousseron UMR 5247 CNRS-UM1-UM2 Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Chimie de Montpellier, 8 rue de l'Ecole Normale, 34296 Montpellier Cedex, France.

出版信息

Bioorg Med Chem Lett. 2008 Dec 15;18(24):6332-5. doi: 10.1016/j.bmcl.2008.10.093. Epub 2008 Nov 1.

DOI:10.1016/j.bmcl.2008.10.093
PMID:18990571
Abstract

A series of 2-substituted-1,3,4-thiadiazole-5-sulfamides was prepared and assayed as inhibitors of several carbonic anhydrase (CA, EC 4.2.1.1) isoforms, the cytosolic CA I and II, the membrane-associated CA IV and the mitochondrial CA VA and VB. The new compounds showed weak inhibitory activity against hCA I (K(I)s of 102 nM-7.42 microM), hCA II (K(I)s of 0.54-7.42 microM) and hCA IV (K(I)s of 4.32-10.05 microM) but were low nanomolar inhibitors of hCA VA and hCA VB, with inhibition constants in the range of 4.2-32 nM and 1.3-74 nM, respectively. Furthermore, the selectivity ratios for inhibiting the mitochondrial enzymes over CA II were in the range of 67.5-415, making these sulfamides the first selective CA VA/VB inhibitors.

摘要

制备了一系列2-取代-1,3,4-噻二唑-5-磺酰胺,并作为几种碳酸酐酶(CA,EC 4.2.1.1)同工型的抑制剂进行了测定,这些同工型包括胞质CA I和II、膜相关CA IV以及线粒体CA VA和VB。新化合物对hCA I(抑制常数K(I)为102 nM - 7.42 μM)、hCA II(K(I)为0.54 - 7.42 μM)和hCA IV(K(I)为4.32 - 10.05 μM)显示出较弱的抑制活性,但对hCA VA和hCA VB是低纳摩尔级抑制剂,抑制常数分别在4.2 - 32 nM和1.3 - 74 nM范围内。此外,抑制线粒体酶相对于CA II的选择性比率在67.5 - 415范围内,使得这些磺酰胺成为首批选择性CA VA/VB抑制剂。

相似文献

1
Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.碳酸酐酶抑制剂:2-取代-1,3,4-噻二唑-5-磺酰胺对线粒体同工酶VA和VB的抑制作用强且具有选择性,对胞质及膜相关的碳酸酐酶I、II和IV的抑制作用较弱。
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6332-5. doi: 10.1016/j.bmcl.2008.10.093. Epub 2008 Nov 1.
2
Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.碳酸酐酶抑制剂。含有苯乙酰基、吡啶乙酰基和噻吩乙酰基尾链的芳香族/杂环磺酰胺类化合物是人类线粒体同工酶VA和VB的有效抑制剂。
Bioorg Med Chem. 2009 Jul 15;17(14):4894-9. doi: 10.1016/j.bmc.2009.06.006. Epub 2009 Jun 9.
3
Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.碳酸酐酶抑制剂。从基于天然产物的酚类文库中鉴定出对人线粒体同工酶 VA 和 VB 具有选择性抑制作用的抑制剂,而对胞质同工酶 I 和 II 则没有抑制作用。
Bioorg Med Chem. 2010 Jan 1;18(1):14-8. doi: 10.1016/j.bmc.2009.11.021. Epub 2009 Nov 20.
4
Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.具有碳酸酐酶抑制活性的新型1,3,4-噻二唑-2-硫酮衍生物的设计、合成及对接研究
Bioorg Med Chem. 2007 Nov 15;15(22):6975-84. doi: 10.1016/j.bmc.2007.07.044. Epub 2007 Aug 22.
5
Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.碳酸酐酶抑制剂。用一系列1,3,4-噻二唑和1,2,4-三唑硫醇抑制胞质和肿瘤相关碳酸酐酶同工酶I、II和IX。
Bioorg Med Chem Lett. 2005 May 2;15(9):2347-52. doi: 10.1016/j.bmcl.2005.02.088.
6
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.碳酸酐酶抑制剂:一系列苯磺酰胺衍生物对人胞质同工酶II和线粒体同工酶V的抑制作用
Bioorg Med Chem Lett. 2004 Nov 15;14(22):5703-7. doi: 10.1016/j.bmcl.2004.07.085.
7
Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.对-(4-苯基三唑-1-基)-苯磺酰胺衍生物对人线粒体碳酸酐酶VA和VB的抑制作用
Bioorg Med Chem Lett. 2008 Aug 15;18(16):4624-7. doi: 10.1016/j.bmcl.2008.07.010. Epub 2008 Jul 10.
8
Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.碳酸酐酶抑制剂。唑尼沙胺是胞质同工酶II和线粒体同工酶V的有效抑制剂:溶液和X射线晶体学研究。
Bioorg Med Chem Lett. 2005 May 2;15(9):2315-20. doi: 10.1016/j.bmcl.2005.03.032.
9
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.碳酸酐酶抑制剂。线粒体同工酶VB作为磺胺类和氨基磺酸盐抑制剂的新靶点。
J Med Chem. 2005 Dec 1;48(24):7860-6. doi: 10.1021/jm050483n.
10
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.碳酸酐酶抑制剂:4-异硫氰酸苯甲酰胺衍生的磺酰胺类化合物对胞质/肿瘤相关碳酸酐酶同工酶I、II和IX的合成及抑制作用
Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80. doi: 10.1016/j.bmcl.2004.09.062.

引用本文的文献

1
A subcellularly targeted photocaged inhibitor for mitochondrial carbonic anhydrase V.一种用于线粒体碳酸酐酶V的亚细胞靶向光笼抑制剂。
Dalton Trans. 2025 Jul 4. doi: 10.1039/d5dt01161b.
2
Structure based exploration of mitochondrial alpha carbonic anhydrase inhibitors as potential leads for anti-obesity drug development.基于结构的线粒体 α 碳酸酐酶抑制剂的探索作为抗肥胖药物开发的潜在先导物。
Daru. 2024 Dec;32(2):907-924. doi: 10.1007/s40199-024-00535-w. Epub 2024 Sep 14.
3
Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease.
线粒体碳酸酐rase VA 和 VB:在健康和疾病中的特性和作用。
J Physiol. 2023 Jan;601(2):257-274. doi: 10.1113/JP283579. Epub 2022 Dec 19.
4
Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities.抗肥胖碳酸酐酶抑制剂:挑战与机遇。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2478-2488. doi: 10.1080/14756366.2022.2121393.
5
Antibacterial and molecular docking studies of newly synthesized nucleosides and Schiff bases derived from sulfadimidines.新合成的磺胺嘧啶核苷和席夫碱的抗菌和分子对接研究。
Sci Rep. 2021 Sep 9;11(1):17953. doi: 10.1038/s41598-021-97297-1.
6
Synthesis and antibacterial evaluation of novel heterocyclic compounds containing a sulfonamido moiety.含磺酰胺基杂环化合物的合成及抗菌活性评价。
Molecules. 2013 Jan 11;18(1):832-44. doi: 10.3390/molecules18010832.